Ann Dalton's brain tumour diagnosis happened in the most unusual of circumstances.
As the head of engagement at the Pharmacy Guild of Australia, she was in the process of cementing a partnership between her organisation and the Cure Brain Cancer Foundation when she began to notice something was wrong.
"I was in the meeting, and I've done them a million times with stakeholders, but I did sit there writing and think, 'my brain is just not working'," she said.
A couple of weeks later, Ms Dalton and husband Martin Shafron were at their GP's clinic, discovering that she had the very disease she was about to raise awareness of through the guild: a malignant brain tumour known as glioblastoma multiforme, or GBM.
"It's the weirdest thing ever," she said of the diagnosis timing, which also came the day before her husband was due to retire.
"Nobody had heard of timing like that happening before. I'm now on the other side of the pharmacy counter."
Since her diagnosis in late January, Ms Dalton has been through surgery, rounds of chemotherapy and radiotherapy, while coping with short-term memory problems, the inability to drive and extended sick leave from work.
People with GBM will be the beneficiaries of a newly-launched program from a international coalition of neurosurgeons planning to trial a new method of treatment.
Although the treatment will not involve any new drugs or therapies, the program known as GBM AGILE will tailor different forms of treatment to subsections of patients based on their kind of molecular alteration.
Half of the people diagnosed with GBM die within a year of diagnosis, and 90 per cent die within three years.
Ms Dalton said the statistics were the most disturbing part of her diagnosis, but the prospect of the new treatment methods gave her hope that those would change.
She also hoped greater public awareness about brain cancer, including her own story, would help spread awareness about the cancer and lead to greater funding.
"I was in health and I was alarmed at the statistics, and I think they were the same [survival] statistics my sister was facing during her fight with brain cancer 20 years ago," she said.
"But just think of the success that breast cancer treatment has had because of the funding behind it, the community awareness and celebrity involvement; it's just been fantastic. It would be great to think governments and the community could provide the same support for brain cancer."